| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine.
|
J Biol Chem
|
2000
|
1.36
|
|
2
|
5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
|
Eur J Pharmacol
|
2001
|
0.95
|
|
3
|
F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
|
J Pharmacol Exp Ther
|
1998
|
0.91
|
|
4
|
Investigation of the mechanism by which ketanserin prolongs the duration of the cardiac action potential.
|
J Cardiovasc Pharmacol
|
1995
|
0.79
|
|
5
|
Prevention by specific chemical classes of alpha 1-adrenoceptor antagonists of veratrine-contractures in rat left atria independently of alpha 1-adrenoceptor blockade.
|
Br J Pharmacol
|
1994
|
0.76
|
|
6
|
F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet.
|
Atherosclerosis
|
2001
|
0.76
|
|
7
|
Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture.
|
Biochem Pharmacol
|
2001
|
0.76
|
|
8
|
Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
|
Br J Pharmacol
|
1995
|
0.75
|
|
9
|
Evidence for partial agonist properties of daltroban (BM 13,505) at TP receptors in the anaesthetized open-chest rat.
|
Naunyn Schmiedebergs Arch Pharmacol
|
1997
|
0.75
|
|
10
|
[Crystalline polymorphism of eflucimibe].
|
Ann Pharm Fr
|
2002
|
0.75
|
|
11
|
Characterization of polymorphs and solvates of 3-amino-1-(m-trifluoromethylphenyl)-6-methyl-1H-pyridazin-4-one.
|
J Pharm Sci
|
1992
|
0.75
|